These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 16115906)
1. A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma. Le QT; Jones CD; Yau TK; Shirazi HA; Wong PH; Thomas EN; Patterson BK; Lee AW; Zehnder JL Clin Cancer Res; 2005 Aug; 11(16):5700-7. PubMed ID: 16115906 [TBL] [Abstract][Full Text] [Related]
2. Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Lin JC; Wang WY; Liang WM; Chou HY; Jan JS; Jiang RS; Wang JY; Twu CW; Liang KL; Chao J; Shen WC Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1342-8. PubMed ID: 17449194 [TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma. Ishii H; Ogino T; Berger C; Köchli-Schmitz N; Nagato T; Takahara M; Nadal D; Harabuchi Y J Med Virol; 2007 May; 79(5):562-72. PubMed ID: 17385697 [TBL] [Abstract][Full Text] [Related]
4. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347 [TBL] [Abstract][Full Text] [Related]
5. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. Lin JC; Wang WY; Chen KY; Wei YH; Liang WM; Jan JS; Jiang RS N Engl J Med; 2004 Jun; 350(24):2461-70. PubMed ID: 15190138 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma]. Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842 [TBL] [Abstract][Full Text] [Related]
8. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma. Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study. Wei WI; Yuen AP; Ng RW; Ho WK; Kwong DL; Sham JS Head Neck; 2004 Oct; 26(10):878-83. PubMed ID: 15390201 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen. Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466 [TBL] [Abstract][Full Text] [Related]
12. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma]. Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192 [TBL] [Abstract][Full Text] [Related]
13. Clinical value of Epstein-Barr virus DNA levels in peripheral blood samples of Italian patients with undifferentiated carcinoma of nasopharyngeal type. Bortolin MT; Pratesi C; Dolcetti R; Bidoli E; Vaccher E; Zanussi S; Tedeschi R; De Paoli P Cancer Lett; 2006 Feb; 233(2):247-54. PubMed ID: 15907367 [TBL] [Abstract][Full Text] [Related]
14. Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study. Mäkitie AA; Reis PP; Irish J; Zhang T; Chin SF; Chen X; Marriott C; Keller A; Perez-Ordonez B; Kamel-Reid S; Siu LL Head Neck; 2004 Sep; 26(9):815-22. PubMed ID: 15350028 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537 [TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA. Hong RL; Lin CY; Ting LL; Ko JY; Hsu MM Cancer; 2004 Apr; 100(7):1429-37. PubMed ID: 15042677 [TBL] [Abstract][Full Text] [Related]
17. [Correlation between the kinetics of plasma EBV DNA levels and clinical response during treatment in patients with nasopharyngeal carcinoma]. Peng PJ; Zhao C; Liao H; Wang FQ; Zhang L Ai Zheng; 2002 Aug; 21(8):817-22. PubMed ID: 12478884 [TBL] [Abstract][Full Text] [Related]
18. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area. Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178 [TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients. Chan KC; Leung SF; Yeung SW; Chan AT; Lo YM Clin Cancer Res; 2008 Aug; 14(15):4809-13. PubMed ID: 18676752 [TBL] [Abstract][Full Text] [Related]
20. [Quantitative analysis of plasma Epstein-Barr virus (EBV) DNA for monitoring of recurrence and metastasis in nasopharyngeal carcinoma patients after radiotherapy]. Li YH; Shao JY; Zhao MQ; Gao HY; Li LR; Guan ZZ; Zeng YX Ai Zheng; 2003 Jun; 22(6):645-8. PubMed ID: 12948418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]